Intensified-dose (4 gm/m2) cyclophosphamide and granulocyte colony- stimulating factor administration for hematopoietic stem cell mobilization in refractory rheumatoid arthritis

Arthritis and Rheumatism

Volumn 42, Issue 11, 1999, Pages 2275-2280

  Breban, Maxime ^a   Dougados, Maxime ^a   Picard, Françoise ^a   Zompi, Simona ^a   Marolleau, Jean Pierre ^b   Bocaccio, Catherine ^c   Heshmati, Fahrad ^a   Mezieres, Maryse ^a   Dreyfus, François ^a   Bouscary, Didier ^a  

^a Univ René Descartes ^*  (France)

^b SAINT LOUIS HOSPITAL   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BIOLOGICAL THERAPY; CASE REPORT; DISEASE ACTIVITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; RELAPSE; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEASIBILITY STUDIES; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0033513063     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199911)42:11<2275::AID-ANR3>3.0.CO;2-6     Document Type: Article

References (17)

1. Snowden JA, Biggs JC, Brooks PM. Autologous blood stem cell transplantation for autoimmune diseases. Lancet 1996;348:1112-3.
2. Van Bekkum DW. BMT in experimental autoimmune diseases. Bone Marrow Transplant 1993;11:183-7.
3. Snowden JA, Kearney P, Kearney A, Cooley HM, Grigg A, Jacobs P, et al. Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation. Arthritis Rheum 1998;41: 453-9.
4. Jondeau K, Job-Deslandre C, Bouscary D, Khanlou N, Menkes C-J, Dreyfus F. Remission of nonerosive polyarthritis associated with Sjögren's syndrome after autologous hematopoietic stem cell transplantation for lymphoma. J Rheumatol 1997;24:2466-8.
5. McGonagle D, Rawstron A, Richards S, Isaacs J, Bird H, Jack A, et al. A phase 1 study to address the safety and efficacy of granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in active rheumatoid arthritis. Arthritis Rheum 1997;40:1838-42.
6. Snowden JA, Biggs JC, Milliken ST, Fuller A, Staniforth D, Passuello F, et al. A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis. Bone Marrow Transplant 1998;22:1035-41.
7. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
8. Van Gestel AM, Prevoo MLL, van 't Hof MA, van Rijswijk MH, van de Putte LBA, van Riel PLCM. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria. Arthritis Rheum 1996;39:34-40.
9. + cell determination by flow cytometry: International Society of Hematotherapy and Graft Engineering. J Hematother 1996;5:213-26.
10. Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. QJM 1968;37:393-406.
11. Fries JF, Spitz PW, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
12. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
13. Joske DJL. Autologous bone-marrow transplantation for rheumatoid arthritis [letter]. Lancet 1997;350:337-8.
14. Durez P, Toungouz M, Schandené L, Lambermont M, Goldman M. Remission and immune reconstitution after T-cell-depleted stem-cell transplantation for rheumatoid arthritis [letter]. Lancet 1998;352:881.
15. Burt RK, Traynor AE, Pope R, Schroeder J, Cohen B, Karlin KH, et al. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation. Blood 1998;92:3505-14.
16. Hakim FT, Cepeda R, Kaimei S, Mackall CL, MacAtee N, Zujewski J, et al. Constraints on CD4 recovery postchemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood 1997;9:3789-98.
17. - T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 1996;97:2027-37.